<p>Effect of estradiol and tamoxifen on Y<sub>1</sub>R expression by MCF-7 (L) xenografts in vivo determined by autoradiography using the selective Y<sub>1</sub>R antagonist [<sup>3</sup>H]-UR-MK114 (3 nM). Subcutaneously grown tumors from NMRI (nu/nu) mice bearing subcutaneous 17β-estradiol depots. The control group (3 mice, C1–C3) was treated with the vehicle (PEG400/1.8% NaCl, 1∶1). Tamoxifen group (3 mice, T1–T3): A cumulative dose of tamoxifen citrate (36 mg/kg, dissolved in PEG400/1.8% NaCl, 1∶1, at a concentration of 2.4 mg/mL) was administered by injecting three times (on day 2, 6 and 10 after explantation of the estrogen depots) 12 mg/kg subcutaneously.</p
<p>Tumour uptake (A), tumour-to-blood ratios (B), and tumour-to-surrounding muscle ratios (C) of E3S...
Tamoxifen, a selective estrogen receptor modulator (SERM), is an effective treatment for breast canc...
We evaluated the effect of tamoxifen (TAM) on tumor development in proto-neu transgenic mice that sp...
<p>Tumor growth kinetics of MCF7 Xenograft treated with EpApt-siEp. Female nude mice (Hsd: Athymic N...
The MXT mouse mammary carcinoma is a new transplantable tumour which contains significant amounts of...
IntroductionDuctal carcinoma in situ (DCIS) is a noninvasive premalignant lesion and is considered a...
<p>(A) Inhibition of tumor growth by compound 7. Total 5 × 10<sup>6</sup> HCT116 cells were subcutan...
The ability to maintain and study human tissues in in-vivo environment has proved to be a valuable t...
<div><p>The neuropeptide Y (NPY) Y<sub>1</sub> receptor (Y<sub>1</sub>R) has been suggested as a tum...
<p>Female athymic nu/nu mice were ovariectomized and subcutaneously implanted with either an estradi...
The neuropeptide Y (NPY) Y(1) receptor (Y(1)R) has been suggested as a tumor marker for in vivo imag...
<p> Effect of the pure ER antagonist fulvestrant on the estrogen stimulated Y<sub>1</sub>R expressio...
<p>A) Tumor growth inhibition curve in female athymic nude mice bearing MDA-MB-231 tumor xenografts ...
Purpose: Cross-resistance is an important issue for the evaluation of new antiestrogens to treat adv...
The neuropeptide Y (NPY) Y1 receptor (Y1R) has been suggested as a tumor marker for in vivo imaging ...
<p>Tumour uptake (A), tumour-to-blood ratios (B), and tumour-to-surrounding muscle ratios (C) of E3S...
Tamoxifen, a selective estrogen receptor modulator (SERM), is an effective treatment for breast canc...
We evaluated the effect of tamoxifen (TAM) on tumor development in proto-neu transgenic mice that sp...
<p>Tumor growth kinetics of MCF7 Xenograft treated with EpApt-siEp. Female nude mice (Hsd: Athymic N...
The MXT mouse mammary carcinoma is a new transplantable tumour which contains significant amounts of...
IntroductionDuctal carcinoma in situ (DCIS) is a noninvasive premalignant lesion and is considered a...
<p>(A) Inhibition of tumor growth by compound 7. Total 5 × 10<sup>6</sup> HCT116 cells were subcutan...
The ability to maintain and study human tissues in in-vivo environment has proved to be a valuable t...
<div><p>The neuropeptide Y (NPY) Y<sub>1</sub> receptor (Y<sub>1</sub>R) has been suggested as a tum...
<p>Female athymic nu/nu mice were ovariectomized and subcutaneously implanted with either an estradi...
The neuropeptide Y (NPY) Y(1) receptor (Y(1)R) has been suggested as a tumor marker for in vivo imag...
<p> Effect of the pure ER antagonist fulvestrant on the estrogen stimulated Y<sub>1</sub>R expressio...
<p>A) Tumor growth inhibition curve in female athymic nude mice bearing MDA-MB-231 tumor xenografts ...
Purpose: Cross-resistance is an important issue for the evaluation of new antiestrogens to treat adv...
The neuropeptide Y (NPY) Y1 receptor (Y1R) has been suggested as a tumor marker for in vivo imaging ...
<p>Tumour uptake (A), tumour-to-blood ratios (B), and tumour-to-surrounding muscle ratios (C) of E3S...
Tamoxifen, a selective estrogen receptor modulator (SERM), is an effective treatment for breast canc...
We evaluated the effect of tamoxifen (TAM) on tumor development in proto-neu transgenic mice that sp...